Category: Uncategorized

Targeted Cancer Therapies

March 29, 2011 at 1:50 pm

Many of today’s oncological therapies take a targeted approach towards combating cancer in order to reduce the amount of collateral damage on the patient’s healthy cells. Since traditional cancer therapies are notorious for their many harmful side-effects, researchers seek to develop therapies that affect only diseased cells. At Boston University, Professors Remco A. Spanjaard and […]

By jking | Comments (0)

Start-up Profile: Predictus

March 28, 2011 at 3:41 pm

Incorporated on December 31st of last year, Predictus has developed a companion diagnostic for a class of oncology drugs called topoisomerase 1 (topo1) inhibitors. Meant to address the low response rates of topo1 inhibitor therapy patients, Predictus’ diagnostic will save valuable time for cancer patients and provide a powerful decision tool for physicians. Dr. Ajit […]

By jking | Comments (0)

Universities Make Good Drugs

February 17, 2011 at 5:18 pm

Researchers from Boston University School’s of Medicine (BUSM), Management (SMG), Law (LAW), and Office of Technology Development (OTD) along with collaborators from the National Institutes of Health (NIH) believe that public-sector research has had a more immediate effect on improving public health than was previously realized. The findings, which appear as a Special Article in the […]

By jjensen | Comments (0)

Boston University researcher shows Microrobotic Vascular Surgery System at TEDMED2010

November 4, 2010 at 2:50 pm

Boston University researcher Pierre Dupont shows off the tiny surgical robot he has been developing in collaboration with Children’s Hospital Boston. This video shows a demo from TEDMED2010:

By admin | Comments (0)